Sequential afatinib (afa) and osimertinib (osi) in patients (pts) with advanced EGFR mutation-positive (EGFRm plus ) NSCLC who acquire the T790M resistance mutation: A non-interventional cohort study (UpSwinG)

  • Popat, S.; 
  • Jung, H. A.; 
  • Lee, S. Yup; 
  • Hochmair, M. J.; 
  • Lee, S. H.; 
  • 외 8명
Citations

WEB OF SCIENCE

1
제목
Sequential afatinib (afa) and osimertinib (osi) in patients (pts) with advanced EGFR mutation-positive (EGFRm plus ) NSCLC who acquire the T790M resistance mutation: A non-interventional cohort study (UpSwinG)
저자
Popat, S.; Jung, H. A.; Lee, S. Yup; Hochmair, M. J.; Lee, S. H.; Escriu, C.; Lee, M. K.; Migliorino, M. R.; Lee, Y. C.; Girard, N.; Daoud, H.; Maerten, A.; Miura, S.
DOI
10.1016/j.annonc.2021.08.1828
발행일
2021
유형
Meeting Abstract
저널명
Annals of Oncology
권
32
페이지
S971 ~ S972